Yes, the Star Trek: Strange New Worlds EPs have heard the fan complaints about Season 4's...
The Nationals announced that right-hander Josiah Gray has been reinstated from the 60-day...
Businessman Adam Castillo had been detained by authorities for three months on breach of t...
Gianni Infantino's World Cup selloff plan has faced global backlash with English FA latest...
Washington Capitals captain under fire for appearing in an election campaign video for Put...
Countries
Opinion
Soros-funded DA Larry Krasner may have finally taken his ‘free all criminals’ too far
Kim Kardashian targets youth sports with ‘Team Moms’ — but here’s what she’s missing
We ran the data on trans teen suicide panic — and found the claims are misleading
$60 million NYC housing-seizure debacle doesn’t deter Mamdani’s geniuses
Miranda Devine: Trump was nearly assassinated more than 2 years ago. We deserve the truth
Don’t rely on poison pills to stop the billionaire tax — speak out now
-
NY Times News ( Middle East ) 2026/4/30David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IM...
-
Independent ( Yemen ) 2026/4/2The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
-
PR Newswire ( Middle East ) 2026/3/28Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz mon...
-
Gizmodo ( Middle East ) 2026/1/9People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
-
Quartz ( Middle East ) 2025/10/6European Association for the Study of Obesity says the drugs are so effective, they should be used for almost all obesity patients
-
Los Angeles Daily News ( Middle East ) 2025/5/12By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...
-
Quartz ( Middle East ) 2025/5/12Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...
-
News10NBC ( Middle East ) 2025/5/12People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...
- Quartz ( Middle East ) 2025/4/1
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and...
- Ukiah Daily Journal ( Middle East ) 2025/3/5
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Related ArticlesHealth |...
